Background Sputum-based diagnostic methods for pulmonary tuberculosis (PTB) are challenging for patients who cannot produce sputum. Non-sputum-based approaches, such as tongue swab (TS), can address this gap. This study conducts an early Health Technology Assessment (HTA) of TS for PTB diagnosi

I would like to express my gratitude for the opportunity and the support from the UNITE initiative under the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B) to be part of the panel discussion at the “Early Career Path” session during the I

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr

Thailand’s increasing demand for coal and fossil fuel-based energy has substantial climate, environmental, and public health consequences. In response, the Ministry of Energy has ambitious plans to increase the share of renewable energy to over 50% by 2037. A high priority intervention included in this plan is photovoltaic systems or ‘solarisat

In 2007, there were an estimated 58 million deaths worldwide and, according to the WHO, more than half of these deaths (35 million) were caused by chronic diseases.  Another study estimates that the number of deaths caused by chronic diseases will rise to 50 million in 2020.  The economic burden of

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le

Policymakers across the world are regularly required to make crucial decisions about resource allocation and prioritize interventions – medicine A or medicine B, subsidize heart surgery or expand the immunization program. This process is required to be transparent, accountable a

Apiwat Piriyapol is a research associate at Medical Innovation Development and Assessment Support (MIDAS). His training was in labour economics with experience in urban health economics. His current interest is in conducting medical technology assessment to promote advanced technology to the healthcare system.